Shares

Shares
royal mail

Royal Mail upgraded by brokers after stronger results

Royal Mail shares are up nearly 4 percent this morning, after upgrades from multiple brokers. Cantor Fitzgerald reiterated its buy rating on the stock, raising...
Lloyds

Lloyds bets big on credit cards buying MBNA for £1.9bn

In a week that is typically quite quiet in the markets as attentions turn to the festive period Lloyds (LON:LLOY) has announced it's first...
JD Sports

Profits up 81 percent at JD Sports, despite ‘prison-like’ warehouse allegations

Sports store JD Sports (LON:JD) reported record profits on Tuesday, with a boost to fashion fitness wear sending shares up nearly 10 percent. Operating profit at...

SABMiller accepts InBev bid

Shares in brewer SABMiller (LON:SAB) soared this morning, after it announced that it had accepted a takeover offer from rival AB InBev. The deal has...
diageo

Diageo shares get boost from better-than-expected FY earnings

Shares in drinks maker Diageo (LON:DGE) jumped nearly 7 percent in early trading on Thursday, after the company reported better-than-expected earnings for the year. Operating...
thomas cook

Thomas Cook summer bookings jump, signs of recovery in Turkey and...

Thomas Cook announced on Tuesday summer bookings were up 10% and their Winter programme was 90% sold in trading statement that pointed to a...
wh ireland

Incoming CEO of GKN to leave company in surprise announcement

Shares in engineering firm GKN fell over 6 percent on Thursday, after it was announced that incoming chief executive Kevin Cummings would leave the...

Samsung shares fall despite being on track for highest ever annual...

Electronics giant Samsung saw shares sink on Tuesday morning, despite news that the group is on track for its highest ever annual profits. Shares sunk as...
csf group

Venture Life shares tumble 5pc after trading update

Shares in healthcare group Venture Life (LON:VLG) tanked over 5 percent at market open on Wednesday, despite saying that expected to report a full-year...

N4 Pharma: a consumer-driven reformulation and generics specialist

N4 Pharma (LON:N4P) is a consumer-driven pharmaceutical company developing reformulations of a number of key drugs. These have the potential to produce very attractive...